Neuberger Berman Group LLC Neurocrine Biosciences Inc Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 117,032 shares of NBIX stock, worth $16.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,032
Holding current value
$16.6 Million
% of portfolio
0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$130.4 - $143.74 $15.3 Million - $16.8 Million
117,032 New
117,032 $16.1 Million
Q4 2023

Feb 09, 2024
BUY
$106.07 - $132.76 $319,482 - $399,873
3,012 Added 2.72%
113,757 $15 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $33,377 - $41,570
355 Added 0.32%
110,745 $12.5 Million
Q2 2023

Aug 11, 2023
BUY
$89.53 - $104.87 $9.31 Million - $10.9 Million
103,961 Added 1617.06%
110,390 $10.4 Million
Q1 2023

May 12, 2023
SELL
$94.11 - $123.02 $3,105 - $4,059
-33 Reduced 0.51%
6,429 $650,000
Q4 2022

Feb 13, 2023
SELL
$106.72 - $127.06 $9,177 - $10,927
-86 Reduced 1.31%
6,462 $771,000
Q3 2022

Nov 15, 2022
SELL
$92.03 - $107.81 $105,006 - $123,011
-1,141 Reduced 14.84%
6,548 $696,000
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $15,688 - $20,714
207 Added 2.77%
7,689 $750,000
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $213,582 - $279,499
2,948 Added 65.02%
7,482 $699,000
Q4 2021

Feb 11, 2022
BUY
$79.65 - $106.22 $108,722 - $144,990
1,365 Added 43.07%
4,534 $379,000
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $2,413 - $2,772
28 Added 0.89%
3,169 $301,000
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $17,081 - $19,533
191 Added 6.47%
3,141 $305,000
Q1 2021

May 13, 2021
SELL
$87.57 - $119.4 $28,898 - $39,402
-330 Reduced 10.06%
2,950 $287,000
Q4 2020

Feb 10, 2021
BUY
$86.91 - $108.33 $1,651 - $2,058
19 Added 0.58%
3,280 $315,000
Q3 2020

Nov 12, 2020
BUY
$96.16 - $135.15 $31,732 - $44,599
330 Added 11.26%
3,261 $313,000
Q2 2020

Aug 13, 2020
SELL
$85.09 - $130.36 $4.41 Million - $6.76 Million
-51,832 Reduced 94.65%
2,931 $358,000
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $437,665 - $662,879
-5,827 Reduced 9.62%
54,763 $4.74 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $185,318 - $253,146
-2,135 Reduced 3.4%
60,590 $6.51 Million
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $5.26 Million - $6.37 Million
62,725 New
62,725 $5.65 Million
Q2 2019

Aug 13, 2019
SELL
$72.24 - $91.27 $5.8 Million - $7.33 Million
-80,284 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$69.31 - $91.53 $5.38 Million - $7.11 Million
-77,663 Reduced 49.17%
80,284 $7.07 Million
Q4 2018

Feb 12, 2019
SELL
$68.32 - $124.36 $8.65 Million - $15.7 Million
-126,635 Reduced 44.5%
157,947 $11.3 Million
Q3 2018

Nov 13, 2018
SELL
$98.88 - $125.85 $4.64 Million - $5.9 Million
-46,913 Reduced 14.15%
284,582 $35 Million
Q2 2018

Aug 13, 2018
SELL
$75.3 - $105.99 $2.21 Million - $3.11 Million
-29,300 Reduced 8.12%
331,495 $32.6 Million
Q1 2018

May 08, 2018
SELL
$75.88 - $92.43 $8.8 Million - $10.7 Million
-116,000 Reduced 24.33%
360,795 $29.9 Million
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $1.26 Million - $1.67 Million
21,500 Added 4.72%
476,795 $37 Million
Q3 2017

Nov 15, 2017
BUY
$47.97 - $61.28 $21.8 Million - $27.9 Million
455,295
455,295 $27.9 Million

Others Institutions Holding NBIX

# of Institutions
628
Shares Held
94.4M
Call Options Held
505K
Put Options Held
343K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.6B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email